Do Doctors Say No To High-Dollar Requests?

November 10, 1997

A young woman with fatigue worries that she has multiple sclerosis, like her friend. Because of these concerns, she asks the doctor for a magnetic resonance imagery (MRI) of her head or a referral to a neurologist. Her history and physical examination make MS very unlikely.

How do physicians respond to requests for expensive tests that are likely to have very low yield?

To find out, researchers inserted into the schedules of 39 physicians an actor trained to present the same scenario to each doctor. While the physicians agreed to participate in the project, they did not know who the standardized patient was.

Thomas H. Gallagher, MD, of the Washington University School of Medicine in St. Louis, and colleagues at the University of California San Francisco and The Permanente Medical Group of Northern California, published their results in the November Journal of General Internal Medicine.

They found that only three of the 39 physicians agreed to order the MRI, but eight told the patient they might order one in the future. More surprising, 20 of those who refused the MRI request did agree to refer the patient to a neurologist, also not strictly medically indicated.

Few physicians used recommended communication skills, however. Only 10 percent of them asked the patient to say more about her friend's experience with MS, only 25 percent verbalized that MS is scary, and only 33 percent encouraged the patient to call back with questions or concerns.

The researchers noted that their sample size was small, but sufficient to warrant a caution to physicians that they should respond to such requests in ways that provide high quality care and contain costs, while also maintaining patient satisfaction.

They urged physicians to respond to requests for unnecessary services by communicating with empathy and by expanding patient involvement in the plan for care.

The project was supported by grants from the Walter and Elise Haas Fund and the Robert Wood Johnson Clinical Scholars Program.

The Journal of General Internal Medicine (JGIM), a monthly peer-reviewed journal and the official journal of the Society of General Internal Medicine, publishes original articles on research and education in primary care. For more information about JGIM, contact: Margo Alderton, (215) 823-4471.

Posted by the Center for the Advancement of Health (http://www.cfah.org). For information about the Center, contact Richard Hebert, 202-387-2829, rhebert@cfah.org

Center for Advancing Health

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.